None listed
Conditions
Interventions
Drug : The blood introduced into the cell salvage will consist only of the blood shed from the patient after biliary anastomosis during liver transplantation surgery. After the cell salvage is operate
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients undergoing living donor liver transplantation (2) Adult patients (= 19 years) with an ASA physical status of III-IV
Exclusion criteria
Exclusion criteria: (1) Patients undergoing emergency liver transplantation (2) Pediatric patients (< 19 years) (3) Patients who decline to provide consent for study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| chloride | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemoglobin (Hb), hematocrit (Hct), free Hb, osmotic fragility, mean cell volume (MCV), mean corpuscular hemoglobin concentration (MCHC), mean cell hemoglobin (MCH), 2,3-Diphosphoglycerate (2,3-DPG);pH (acid-base balance), Base Excess, HCO3, Sodium (Na), Potassium (K), Calcium (Ca), lactate, lactate dehydrogenase (LDH);IL-6, IL-10, TNF-a, elastase, lysozyme, C3a, C5a, SC5b9, IL-1b, a1-AT(S), IL-4, IL-8 | — |
Countries
Korea, Republic of
Contacts
Public ContactYeonji Noh
Samsung Medical Center
Outcome results
None listed